Yarrow Bioscience

Yarrow Bioscience Debt Growth

The Year-over-Year Debt Growth of Yarrow Bioscience (YARW) as of Oct 24, 2026 is -53.74 %. In the previous year, Year-over-Year Debt Growth was -99.00 % — a change of -45.72% (higher).

Debt Growth

-53.74 %

YoY

-45.72%

Last updated:

Year-over-Year Debt Growth of Yarrow Bioscience is 2024 -53.74 % . Year-over-Year Debt Growth of Yarrow Bioscience was 2023 -99.00 % . It decreases by -45.72% higher compared to the previous year.

The Yarrow Bioscience Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2020
4,869.14 USD
Jan 1, 2021
-99.00 USD
Jan 1, 2024
-53.74 USD
The Yarrow Bioscience Debt Growth history
YEARDebt GrowthYoY
-53.74 %-45.72%
-99.00 %-102.03%
4,869.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Yarrow Bioscience Stock analysis

What does Yarrow Bioscience do? Yarrow Bioscience Inc, based in New York, is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. Its lead candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for treating Graves' disease and thyroid eye disease. Listed on 25 January 2018, the company operates with a team of 10 employees. Yarrow Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yarrow Bioscience stock

Year-over-Year Debt Growth of Yarrow Bioscience is -53.74 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Yarrow Bioscience since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Yarrow Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Yarrow Bioscience

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Yarrow Bioscience